ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2178

Online Education Significantly Improved Rheumatologists’ Knowledge of the Diagnosis and Management of Sjögren’s Disease

Elaine Bell1, michele Bombardieri2 and Alessia Piazza3, 1MEDSCAPE GLOBAL, LONDON, United Kingdom, 2Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, UK, London, United Kingdom, 3Medscape, london, United Kingdom

Meeting: ACR Convergence 2025

Keywords: education, medical, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2159–2194) Professional Education Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Sjögren’s disease is a chronic autoimmune disease affecting multiple organ systems beyond the eyes and mouth. Diagnosis is challenging and therapy is often initiated late. The need for a patient-centered individualized management approach is often underappreciated. Our goal was to assess whether online accredited education could improve rheumatologists’ understanding of the heterogeneous clinical presentation of Sjögren’s disease, the diagnostic approach and the role of B cells in the pathogenesis of Sjögren’s disease, and enhance their confidence in implementing a tailored, patient-centric management approach.

Methods: This online educational activity titled ‘Challenges and Opportunities in the Management of Sjögren’s Disease’ was a 30-minute roundtable discussion with 3 panelists and a patient, accompanied by slides and video. Responses to 3 multiple-choice knowledge questions and 1 self-efficacy, 5-point Likert scale confidence question were analyzed. Educational effect was assessed using a repeated-pair design, pre-/post-assessment. A paired samples t-test was conducted for significance testing on overall average number of correct responses and for confidence rating. A series of McNemar’s tests were conducted at the question level (5% significance level, P < .05). Cohen’s d with correction for paired samples estimated the effect size of the education on number of correct responses (< .20 modest, .20-.49 small, .59-.79 moderate, ≥.80 large). The activity was launched on 13 August 2024 with data collection through 3 October 2024.

Results: Of 1205 rheumatologists who viewed the education within this time period, 80 completed all pre- and post-assessment questions. The average percentage of correct responses across all questions increased from 76% at baseline to 88% post-activity (P < .001), and there was a moderate educational impact (Cohen’s d=0.59). The proportion of rheumatologists answering all 3 questions correctly rose from 49% at baseline to 71% post-activity.Rheumatologists significantly improved their knowledge of the diagnostic approach for Sjögren's disease (68% correct responses at baseline rising to 85% post-activity; P < .001) and the presence of germinal centers in the salivary glands as an indicator of the role of B cells in the pathogenesis of Sjögren's disease (66% pre- vs 81% post-activity; P < .001). Knowledge of the heterogeneous clinical presentation of Sjögren's disease was high at baseline and did not change post education (95% pre- vs 96% post-activity; P =.317).After completing the activity, 33% of rheumatologists reported improved confidence in implementing a tailored, patient-centric management approach in Sjögren's disease.

Conclusion: This online activity significantly improved rheumatologists’ knowledge of the diagnostic approach for Sjögren’s disease and the role of B cells in the pathogenesis of disease. Given the evolving treatment landscape, rheumatologists would benefit from additional education to build their confidence in managing this challenging condition & improve their knowledge of emerging B-cell targeted therapies.


Disclosures: E. Bell: None; m. Bombardieri: Amgen, 5, 12, Personal fees, GlaxoSmithKlein(GSK), 5, 12, Personal fees, Janssen, 5, 12, Personal fees, Ono Pharmaceuticals Co. Ltd, 1, 2, UCB, 12, Personal fees; A. Piazza: None.

To cite this abstract in AMA style:

Bell E, Bombardieri m, Piazza A. Online Education Significantly Improved Rheumatologists’ Knowledge of the Diagnosis and Management of Sjögren’s Disease [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/online-education-significantly-improved-rheumatologists-knowledge-of-the-diagnosis-and-management-of-sjogrens-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/online-education-significantly-improved-rheumatologists-knowledge-of-the-diagnosis-and-management-of-sjogrens-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology